Improved glycaemic control with metformin-glibenclamide combined tablet therapy (Glucovance) in Type 2 diabetic patients inadequately controlled on metformin.
Improved glycaemic control with the combined metformin-glibenclamide tablet therapy (glucovance) in Type 2 diabetic patients had been unreached on metformin.